enVVeno Medical Corp

General ticker "NVNO" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $47.8M

enVVeno Medical Corp does not follow the US Stock Market performance with the rate: -16.5%.

Estimated limits based on current volatility of 5.2%: low 2.53$, high 2.81$

Factors to consider:

  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [3.01$, 7.03$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.85$, 6.73$]

Financial Metrics affecting the NVNO estimates:

  • Negative: Non-GAAP EPS, $ of -1.92 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -27.65 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0.19 <= 0.49
  • Positive: -0.96 < Investing cash flow per share, $ of -0.64

Similar symbols

Short-term NVNO quotes

Long-term NVNO plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $16.89MM $24.93MM $25.24MM
Operating Income $-16.89MM $-24.93MM $-25.24MM
Non-Operating Income $0.36MM $0.26MM $1.72MM
R&D Expense $5.73MM $9.91MM $13.58MM
Income(Loss) $-16.53MM $-24.67MM $-23.52MM
Profit(Loss) $-16.53MM $-24.67MM $-23.52MM
Stockholders Equity $54.40MM $38.73MM $46.20MM
Assets $57.70MM $41.66MM $48.63MM
Operating Cash Flow $-11.85MM $-15.62MM $-18.86MM
Capital expenditure $0.37MM $0.12MM $0.03MM
Investing Cash Flow $-0.37MM $-34.55MM $-7.87MM
Financing Cash Flow $57.61MM $0.00MM $25.79MM
Earnings Per Share* $-1.87 $-2.16 $-1.91

* EPS are Split Adjusted, recent splits may be reflected with a delay.